Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,710 public trials 619 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Active, Not Recruiting

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

NCT05513001

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • Cahaba Derm and skin hlth ctr 27 Birmingham, Alabama, United States
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Acuro Research Inc Little Rock, Arkansas, United States
View all 208 locations
View Trial Details
Active, Not Recruiting

Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus

NCT06787586

Conditions
Atopic Dermatitis (AD), Atopic Eczema, Chronic Pruritus, +17 more
Locations
  • Attovia Clinical Site 103 Encinitas, California, United States
  • Attovia Clinical Site 116 Rocklin, California, United States
  • Attovia Clinical Site 107 Sacramento, California, United States
  • Attovia Clinical Site 109 Coral Gables, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Seal, Stopping Eczema and Allergy Study

NCT03742414

Conditions
Atopic Dermatitis, Atopic Dermatitis Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Sean N. Parker Center for Allergy & Asthma Research at Stanford University Palo Alto, California, United States
  • Division of Pediatric Allergy and Clinical Immunology, National Jewish Health Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain

NCT06415175

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Number : 7240004 Santiago de Compostela, A Coruña [La Coruña], Spain
  • Investigational Site Number : 7240006 Esplugues de Llobregat, Barcelona [Barcelona], Spain
  • Investigational Site Number : 7240005 Oviedo, Principality of Asturias, Spain
  • Investigational Site Number : 7240008 Seville, Sevilla, Spain
View all 15 locations
View Trial Details
Active, Not Recruiting

Investigating Dupilumab's Effect in Asthma by Genotype

NCT03694158

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Montefiore Einstein Clinical Research Center The Bronx, New York, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis

NCT06718101

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272550 Fountain Hills, Arizona, United States
  • Dermatology Research Associates - Los Angeles /ID# 272945 Los Angeles, California, United States
  • Integrative Skin Science and Research /ID# 274243 Sacramento, California, United States
  • Clinical Trials Research Institute /ID# 274234 Thousand Oaks, California, United States
View all 30 locations
View Trial Details

Related conditions